Clarivate amends 8-K with pro forma financials for $600 million LS&H sale to Altaris affiliate
Bitget2026/10/13 20:26- Clarivate issued an amended Form 8-K/A detailing the completed sale of its Life Sciences and Healthcare business to an Altaris affiliate for USD 600 million.
- The transaction closed on Oct. 6, 2026, with Clarivate receiving USD 488.4 million in cash at close, net of closing costs and working-capital adjustments.
- The deal includes a USD 75 million unsecured senior note, with USD 25 million of deferred cash consideration due no later than Jan. 31, 2028.
- Clarivate said the divestiture represents a strategic shift and qualified for discontinued-operations accounting in the third quarter of 2026.
- It does not expect the gain or loss on sale to be material.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stock futures fluctuate by $650 billions due to news related to Jensen Huang
Nikkei Average Index gains expand to 2.78%
Surprise! Japan intervened in the forex market three times this summer, selling a record 154 trillion yen in three days
Japan has confirmed that it intervened in the foreign exchange market three times this summer, buying yen to support the exchange rate, corroborating earlier market reports. This included the first joint intervention with the United States to support the yen in nearly thirty years.
UBS CEO warns: A Democratic sweep could slow down AI capacity building, valuation concerns are "very important"
UBS CEO Ermotti stated that the U.S. midterm elections may slow down AI capacity building and that the valuations are questionable; he also warned of persistent inflation and the risk of contagion in the European bond market.
Crypto prices
More
